Quality of life changes in COPD patients treated with salmeterol.
暂无分享,去创建一个
[1] D. Kellerman,et al. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[2] P. Jones,et al. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.
[3] A. Tosteson,et al. Changes in dyspnea, health status, and lung function in chronic airway disease. , 1995, American journal of respiratory and critical care medicine.
[4] T. W. van der Mark,et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. , 1994, Thorax.
[5] J. Ware,et al. Translating health. The International Quality of Life Assessment (IQOLA) project , 1994 .
[6] P. Jones,et al. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. , 1994, The European respiratory journal.
[7] D. Postma,et al. Quality-of-life in a long-term multicentre trial in chronic nonspecific lung disease: assessment at baseline. The Dutch CNSLD Study Group. , 1993, The European respiratory journal.
[8] H. Magnussen,et al. Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. , 1993, Chest.
[9] J. Palmer,et al. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.
[10] J. Kemp,et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.
[11] J. Palmer,et al. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. , 1992, The European respiratory journal.
[12] G. Colice,et al. Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. , 1992, Chest.
[13] P. Jones,et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.
[14] F. Sciurba,et al. Nasal cannula and transtracheal oxygen delivery. A comparison of patient response after 6 months of each technique. , 1992, The American review of respiratory disease.
[15] P. Jones,et al. The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.
[16] P. Jones,et al. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries. , 1991, The European respiratory journal.
[17] G. Guyatt,et al. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. , 1989, Respiratory medicine.
[18] N. Douglas,et al. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.
[19] P. Jones,et al. Patients' perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors. , 1990, Clinical science.
[20] P Littlejohns,et al. Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. , 1989, The American review of respiratory disease.
[21] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[22] M. Bury,et al. Impairment, disability and handicap in chronic respiratory illness. , 1989, Social science & medicine.
[23] G. Guyatt,et al. A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.
[24] H. D. Short,et al. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. , 1987, The American review of respiratory disease.
[25] C. Wells,et al. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. , 2015, The American review of respiratory disease.
[26] A. Morgan,et al. Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis. , 1983, British medical journal.